全文获取类型
收费全文 | 5677篇 |
免费 | 434篇 |
国内免费 | 59篇 |
专业分类
耳鼻咽喉 | 44篇 |
儿科学 | 149篇 |
妇产科学 | 88篇 |
基础医学 | 718篇 |
口腔科学 | 191篇 |
临床医学 | 670篇 |
内科学 | 937篇 |
皮肤病学 | 64篇 |
神经病学 | 372篇 |
特种医学 | 302篇 |
外科学 | 807篇 |
综合类 | 375篇 |
预防医学 | 519篇 |
眼科学 | 114篇 |
药学 | 375篇 |
3篇 | |
中国医学 | 100篇 |
肿瘤学 | 342篇 |
出版年
2022年 | 45篇 |
2021年 | 60篇 |
2020年 | 63篇 |
2019年 | 73篇 |
2018年 | 75篇 |
2017年 | 78篇 |
2016年 | 78篇 |
2015年 | 86篇 |
2014年 | 129篇 |
2013年 | 180篇 |
2012年 | 284篇 |
2011年 | 261篇 |
2010年 | 172篇 |
2009年 | 185篇 |
2008年 | 280篇 |
2007年 | 270篇 |
2006年 | 241篇 |
2005年 | 246篇 |
2004年 | 197篇 |
2003年 | 160篇 |
2002年 | 170篇 |
2001年 | 193篇 |
2000年 | 180篇 |
1999年 | 166篇 |
1998年 | 100篇 |
1997年 | 83篇 |
1996年 | 90篇 |
1995年 | 75篇 |
1994年 | 74篇 |
1993年 | 60篇 |
1992年 | 78篇 |
1991年 | 95篇 |
1990年 | 92篇 |
1989年 | 80篇 |
1988年 | 90篇 |
1987年 | 84篇 |
1986年 | 79篇 |
1985年 | 93篇 |
1984年 | 71篇 |
1983年 | 48篇 |
1981年 | 40篇 |
1979年 | 58篇 |
1978年 | 39篇 |
1977年 | 38篇 |
1959年 | 41篇 |
1958年 | 66篇 |
1957年 | 75篇 |
1956年 | 73篇 |
1955年 | 83篇 |
1954年 | 51篇 |
排序方式: 共有6170条查询结果,搜索用时 13 毫秒
91.
目的探讨自我效能感与晕船症状的相关,以期寻找影响晕船的心理因素.方法对某院校参加海上实习的123名医疗本科学员用一般自我效能感量表、晕船自我效能感量表于出海作业前进行施测,用晕船症状评分量表于出海作业返回后进行评估.结果晕船自我效能感与晕船症状显著负相关(r=-0.470,P<0.01),而一般自我效能感量表与晕船症状的相关无统计学意义(r=-0.102,P>0.05).结论晕船自我效能感可能为个体发生晕船的心理影响因素之一. 相似文献
92.
Prognostic significance of tumor necrosis in ovarian cancer patients treated with neoadjuvant chemotherapy and interval surgical debulking 总被引:1,自引:0,他引:1
T. LE P. SHAHRIARI L. HOPKINS W. FAUGHT† & M. FUNG KEE FUNG 《International journal of gynecological cancer》2006,16(3):986-990
The objective of this study was to study the significance of tumor necrosis documented at the time of interval surgical debulking after neoadjuvant chemotherapy. Retrospective chart reviews were carried out from 1997 to 2005 to identify ovarian cancer patients treated with neoadjuvant chemotherapy. Patients' demographics together with disease characteristics, treatment-related variables, and outcomes were recorded. Cox proportional hazard models were built to model time to progression using predictor variables such as age, cancer stage, tumor grade, residual disease, percentage change in CA125 level from baseline, and degree of necrosis in resected tumor specimens. One hundred one patients were included in the study. Optimal debulking was achieved in 74% of the patients. Cox regressions revealed three significant predictive variables of time to first progression: younger age (hazard ratio [HR] = 0.95, 95% CI 0.92-0.98, P= 0.004), residual disease (P= 0.048), and the absence/minimal tumor necrosis after three cycles of neoadjuvant chemotherapy (HR = 1.97, 95% CI 1.01-3.87, P= 0.048). The estimated median survival was 50.66 months (95% CI 46.12-55.20). The lack of or minimal tumor necrosis after neoadjuvant chemotherapy is an independent risk factor for recurrent disease. 相似文献
93.
Lynch WR Montoya JP Brant DO Schreiner RJ Iannettoni MD Bartlett RH 《The Annals of thoracic surgery》2000,69(2):351-356
BACKGROUND: An artificial lung with 1 to 6 month work life could act as a bridge to transplantation. A pumpless artificial lung has been developed. METHODS: The artificial lung was placed in series with the native lungs of adult sheep. Hemodynamics were observed, as the right ventricle generated flow through the device. Through a left thoracotomy, two 20-mm grafts were anastomosed in an end-to-side fashion to the pulmonary artery. The grafts were externalized, and directed flow through the chest wall, to the extracorporeal lung. The animals were recovered, weaned from the ventilator, and when standing, flow was diverted through the device. RESULTS: Five of 7 animals survived 24 hours with 75% to 100% of the cardiac output diverted through the device. All animals were active, with interest in food and water, and able to stand. CONCLUSIONS: The right ventricle perfused the artificial lung with 75% to 100% of the cardiac output for 24 hours. This device demonstrates the feasibility of a pumpless pulmonary assist device relying on the right ventricle for perfusion. 相似文献
94.
2,3,4-三氟苯胺经与EMME缩合、环合、氟乙基化、与N-甲基哌嗪缩合和水解反应制得氟罗沙星,前4步反应可被离子溶剂1-丁基-3-甲基咪唑六氟磷酸盐促进,如环合反应温度由300℃降至200℃,总收率61%. 相似文献
95.
Although significant progress has been made in the treatment of patients with acute lung failure in the critical care setting, the mortality rate from acute lung injury and ARDS is unacceptably high, given the numbers of patients treated for these syndromes each year. The improved understanding of the pathophysiology of respiratory failure from basic science and clinical research is reflected in improved survival rates over the years. Advances in the mechanical ventilator (through microprocessor technology); biosurface technology; liquid ventilation; and, in some cases, returning to so-called "antiquated" practices of patient care (e.g., prone positioning) seem to have had an impact nonetheless. As refinement continues to occur in these areas, morbidity and mortality from lung failure will have a lesser impact on patients as physicians treat the consequences of organ failure in the ICU. 相似文献
96.
目的 总结伴IKZF1基因缺失儿童急性淋巴细胞白血病(ALL)的临床特征并观察提高化疗强度对其预后的影响。方法 2015年12月至2018年2月间确诊并按照中国儿童白血病协作组-ALL 2008(CCLG-ALL 2008)方案规范治疗的ALL患儿共278例,根据有无IKZF1基因缺失将其分为IKZF1基因缺失组和IKZF1基因正常组,IKZF1基因缺失组均接受CCLG-ALL 2008高危(HR)方案治疗,IKZF1基因正常组则按临床危险度分型接受不同强度化疗,比较两组的临床特征及无事件生存(EFS)率。结果 278例患儿中共24例(8.6%)检出IKZF1基因外显子大片段缺失。IKZF1基因缺失组初诊时WBC ≥ 50×109/L、BCR-ABL1融合基因阳性、诱导缓解治疗第15天微小残留病≥ 10%、微小残留病-HR、临床危险度-HR所占比例均高于IKZF1基因正常组(P < 0.05)。IKZF1基因缺失组3年EFS率(76%±10%)低于IKZF1基因正常组(84%±4%),但差异无统计学意义(P=0.282);其中,IKZF1基因缺失组-非HR(实际按CCLG-ALL 2008 HR方案化疗)的预计3年EFS率为82%±12%,低于IKZF1基因正常组-非HR(86%±5%),但差异无统计学意义(P=0.436)。结论 伴IKZF1基因缺失的儿童ALL早期治疗反应更差,提高化疗强度可能改善其预后。 相似文献
97.
Ashton A. Connor Robert E. Denroche Gun Ho Jang Mathieu Lemire Amy Zhang Michelle Chan-Seng-Yue Gavin Wilson Robert C. Grant Daniele Merico Ilinca Lungu John M.S. Bartlett Dianne Chadwick Sheng-Ben Liang Jenna Eagles Faridah Mbabaali Jessica K. Miller Paul Krzyzanowski Heather Armstrong Steven Gallinger 《Cancer cell》2019,35(2):267-282.e7
98.
99.
Antiangiogenic gene therapy of cancer utilizing a recombinant adenovirus to elevate systemic endostatin levels in mice 总被引:41,自引:0,他引:41
Feldman AL Restifo NP Alexander HR Bartlett DL Hwu P Seth P Libutti SK 《Cancer research》2000,60(6):1503-1506
Gene therapy represents a possible alternative to the chronic delivery of recombinant antiangiogenic proteins to cancer patients. Inducing normal host tissues to produce high circulating levels of these proteins may be more effective than targeting antiangiogenic genes to tumor tissue specifically. Previously reported gene therapy approaches in mice have achieved peak circulating endostatin levels of 8-33 ng/ml. Here we report plasma endostatin levels of 1770 ng/ml after administration of a recombinant adenovirus. Growth of MC38 adenocarcinoma, which is relatively resistant to adenoviral infection, was inhibited by 40%. These findings encourage gene delivery approaches that use the host as a "factory" to produce high circulating levels of antiangiogenic agents. 相似文献
100.
目的:研究针灸预处理对Wistar大鼠癌前病变胃黏膜干预作用和对血清CEA的影响。方法:将50只Wistar雄性大鼠随机分为4组,其中空白对照组10只;其余40只大鼠自由饮用100gg/mL的N-甲基-N’-硝基-N-亚硝基胍(MNNG)6个月诱发大鼠胃癌模型,模型组20只;艾灸组和针刺组均10只,在造模3个月以后对足三里和梁门穴进行相应的治疗干预。处死大鼠后取胃黏膜进行HE染色,光镜下观察各组大鼠胃黏膜形态,并采用IPP6.0图像分析软件比较各组胃黏膜细胞核质比。股动脉留取大鼠血液,ELlSA法检测血清CEA。结果:光镜结果显示,艾灸和针刺预处理组大鼠胃黏膜相对于模型组大鼠炎症和异型性等变化较轻;模型组核质(面积)比为1.51±0.69,明显高于空白对照组0.85±0.33,P〈0.001;艾灸组为0.70±0.29,小于模型组,P-0.0064;针刺组为0.99±0.43,亦小于模型组,P=0.0400。酶联免疫吸附实验(enzyme—linked immuno sorbent assay,ELISA)结果显示,模型组血清CEA为(372.42±137.61)og/mL,较空白组(243.13±59.07)iog/mL升高,P-0.0072;艾灸组为(285.63±122.14)pg/mL,较模型组降低,P=0.0445;针刺组为(302.89±ll0.02)pg/mL,较模型组降低,但差异无统计学意义,P=0.4020。结论:针灸预处理能够改善MNNG导致的大鼠胃黏膜癌前病变的组织学表现和降低血清CEA浓度。 相似文献